https://www.taxtmi.com/caselaws?id=788975 Following the 2016 amendment to section 35(2AB), weighted deduction for in-house R&D was confined to the expenditure quantified by the prescribed authority in Form 3CL, and no higher claim could be allowed. MEIS receipts were treated as capital receipts and therefore excluded from taxable income and from book profit adjustment under section 115JB in the absence of a specific statutory add-back. Loss on investment in a subsidiary, made for business purposes and commercial expediency, was accepted as a business loss rather than a capital loss, and the absence of a revised return did not bar the claim when raised in appeal. en-us Fri, 27 Mar 2026 00:00:00 +0530 Wed, 01 Apr 2026 07:51:07 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=788975 Following the 2016 amendment to section 35(2AB), weighted deduction for in-house R&D was confined to the expenditure quantified by the prescribed authority in Form 3CL, and no higher claim could be allowed. MEIS receipts were treated as capital receipts and therefore excluded from taxable income and from book profit adjustment under section 115JB in the absence of a specific statutory add-back. Loss on investment in a subsidiary, made for business purposes and commercial expediency, was accepted as a business loss rather than a capital loss, and the absence of a revised return did not bar the claim when raised in appeal. Case-Laws Income Tax Fri, 27 Mar 2026 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=788975